Skip to content

Microbiological Profile of VAP Patients in Respiratory ICU

Microbiological Profile of Ventilator Associated Pneumonia in Respiratory Intensive Care Unit of Assiut University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05738928
Acronym
VAP
Enrollment
86
Registered
2023-02-22
Start date
2023-02-28
Completion date
2024-02-29
Last updated
2023-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VAP - Ventilator Associated Pneumonia

Brief summary

Identification of the microbial profile of Ventilator associated pneumonia causing microorganisms among Respiratory ICU patients .

Detailed description

Ventilator-associated pneumonia (VAP) is one of the common serious infectious diseases encountered in the intensive care unit (ICU), which highly affects the healthcare cost and patient prognosis. All-cause of mortality associated with VAP has been reported to range from 20% to 50%. The etiology of VAP and their antimicrobial susceptibility pattern varies with different patient populations and types of ICUs. VAP may be caused by a wide spectrum of bacterial pathogens, which may be polymicrobial and are rarely due to viral or fungal pathogens in immune-competent hosts. Common etiologic agents are Gram-negative bacilli such as Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Acinetobacter spp. and Staphylococcus aureus among Gram-positive cocci. Due to the increased incidence of MDR organisms in Intensive Care Units (ICUs), early and correct diagnosis of VAP is mandatory for optimal antibiotic therapy. The frequency of specific MDR pathogens causing VAP varies in hospitals, patient populations. Also varies according underlying disease. this study will be conducted in respiratory intensive care unit, chest disease and tuberculosis department at Assiut university hospitals.

Interventions

DIAGNOSTIC_TESTblood and sputum culture

Noninvasive sampling ( Endo Tracheal Aspiration) for staining and culture. Blood culture .

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Mechanically ventilated patient who developed pneumonia after48 hours after endotracheal intubation. 2. Age \> 18 years.

Exclusion criteria

1. Patients with clinical and radiological signs suggestive of pneumonia before intubation (community acquired pneumonia or hospital acquired pneumonia) 2. Patients age ≤18 years old

Design outcomes

Primary

MeasureTime frameDescription
Microbiological profile of ventilator associated pneumonia in Respiratory ICU in Assiut University Hospital.1 yearIdentify the microbial profile of VAP causing microorganisms among ICU patients, antimicrobial susceptibility patterns among the frequently isolated organisms and resistant strains.

Contacts

Primary ContactManar A Hassan, bacheoler
manarabdelhameed89@yahoo.com+201152808012
Backup ContactManar A hassan, diploma
manarabdelhameed89@gmail.com*201007090074

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026